NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
15.41
-0.61 (-3.81%)
Nov 16, 2026, 4:00 PM EST - Market closed
NeoGenomics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 787.75 | 727.33 | 660.57 | 591.64 | 509.73 | 484.33 | |
Revenue Growth | 11.08% | 10.11% | 11.65% | 16.07% | 5.24% | 8.97% |
Cost of Revenue | 435.08 | 413.44 | 370.47 | 347.04 | 321.83 | 297.27 |
Gross Profit | 352.67 | 313.89 | 290.1 | 244.6 | 187.9 | 187.06 |
Selling, General & Admin | 356.47 | 346.46 | 330.04 | 313.94 | 310.68 | 283.94 |
Research & Development | 39.33 | 37.08 | 31.16 | 27.31 | 30.33 | 21.87 |
Operating Expenses | 395.8 | 383.54 | 361.2 | 341.25 | 341 | 305.81 |
Operating Income | -43.13 | -69.65 | -71.1 | -96.65 | -153.11 | -118.75 |
Interest Expense | -3.25 | -3.75 | -6.62 | -6.91 | -7.58 | -8.22 |
Interest & Investment Income | 5.21 | 9.07 | 18.43 | 16.9 | 6.08 | 112.4 |
Other Non Operating Income (Expenses) | 0.05 | 0.3 | -0.38 | 0.64 | -0.21 | -0.5 |
EBT Excluding Unusual Items | -41.12 | -64.03 | -59.66 | -86.01 | -154.83 | -15.08 |
Merger & Restructuring Charges | -4.7 | -4.7 | -6.66 | -11.09 | -4.52 | - |
Impairment of Goodwill | - | -3.5 | - | - | - | - |
Asset Writedown | -0.63 | -23.85 | - | - | - | - |
Legal Settlements | -0.41 | -11.28 | -13.75 | - | - | - |
Other Unusual Items | 10.68 | -2.9 | -0.6 | - | - | - |
Pretax Income | -36.18 | -110.27 | -80.68 | -97.1 | -159.34 | -15.08 |
Income Tax Expense | -3.88 | -2.24 | -1.95 | -9.13 | -15.09 | -6.73 |
Net Income | -32.3 | -108.03 | -78.73 | -87.97 | -144.25 | -8.35 |
Net Income to Common | -32.3 | -108.03 | -78.73 | -87.97 | -144.25 | -8.35 |
Net Income Growth | - | - | - | - | - | - |
Shares Outstanding (Basic) | 129 | 128 | 127 | 126 | 124 | 120 |
Shares Outstanding (Diluted) | 129 | 128 | 127 | 126 | 124 | 120 |
Shares Change | 1.00% | 1.14% | 0.92% | 1.03% | 3.55% | 7.31% |
EPS (Basic) | -0.25 | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 |
EPS (Diluted) | -0.25 | -0.84 | -0.62 | -0.70 | -1.16 | -0.07 |
EPS Growth | - | - | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -28.58 | -21.78 | -34.04 | -30.71 | -96.88 | -90.87 |
Free Cash Flow Per Share | -0.22 | -0.17 | -0.27 | -0.24 | -0.78 | -0.76 |
Gross Margin | 44.77% | 43.16% | 43.92% | 41.34% | 36.86% | 38.62% |
Operating Margin | -5.47% | -9.57% | -10.76% | -16.34% | -30.04% | -24.52% |
Profit Margin | -4.10% | -14.85% | -11.92% | -14.87% | -28.30% | -1.72% |
Free Cash Flow Margin | -3.63% | -2.99% | -5.15% | -5.19% | -19.01% | -18.76% |
EBITDA | 22.76 | -1.82 | 1.45 | -24.07 | -83.68 | -65.4 |
EBITDA Margin | 2.89% | -0.25% | 0.22% | -4.07% | -16.42% | -13.50% |
D&A For EBITDA | 65.89 | 67.82 | 72.55 | 72.58 | 69.43 | 53.35 |
EBIT | -43.13 | -69.65 | -71.1 | -96.65 | -153.11 | -118.75 |
EBIT Margin | -5.47% | -9.57% | -10.76% | -16.34% | -30.04% | -24.52% |
Revenue as Reported | - | - | - | - | - | 484.33 |